Astrazeneca (AZN) Current Taxes (2009 - 2026)

Astrazeneca (AZN) has reported Current Taxes for 18 consecutive years, with -$1.3 billion the latest figure, recorded in Q1 2026.

• In Q1 2026, Current Taxes rose 21.56% year-over-year to -$1.3 billion; the TTM figure through Mar 2026 stood at -$1.3 billion (up 21.56% YoY), while the FY2025 annual figure was -$1.1 billion, down 177.1% from the prior year.
• Current Taxes came in at -$1.3 billion for Q1 2026 at Astrazeneca, down from -$1.1 billion in the prior quarter.
• The five-year high for Current Taxes was $1.6 billion in Q4 2023, with the low at -$1.7 billion in Q1 2025.
• Average Current Taxes over 5 years is -$837.5 million, with a median of -$1.2 billion recorded in 2023.
• Across the five-year window, Current Taxes soared 76.79% in 2023 and plunged 177.1% in 2025, its largest moves.
• Year by year, Current Taxes stood at $896.0 million in 2022, then surged by 76.79% to $1.6 billion in 2023, then declined by 11.24% to $1.4 billion in 2024, then plunged by 177.1% to -$1.1 billion in 2025, then decreased by 19.83% to -$1.3 billion in 2026.
• According to Business Quant data, Current Taxes over the past three periods registered -$1.3 billion, -$1.1 billion, and -$1.3 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.